Skip to content

Acute Exacerbation of COPD and Physical Activity - Preliminary Study

Acute Exacerbation of COPD and Physical Activity - Preliminary Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01871246
Enrollment
23
Registered
2013-06-06
Start date
2013-02-28
Completion date
2021-07-01
Last updated
2021-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

People with chronic obstructive pulmonary disease (COPD) are very sedentary and efforts to establish an active lifestyle are challenging because of periodic acute exacerbations of COPD that interrupt physical activity patterns and contribute to further decline in physical activity. The purpose of this preliminary research is to learn more about the experience of acute exacerbations of COPD (AECOPD) from the perspective of the patient and his/her family and to learn how AECOPDs affect physical activity.

Detailed description

Individuals with chronic obstructive pulmonary disease (COPD) are very sedentary and their physical activity is often interrupted by acute exacerbations of COPD (AECOPD). Little is known about the expectations had by individuals with COPD and the effects of these expectations on their physical activity. To increase the understanding of these expectations in people with COPD, a study is proposed to explore their experience of daily fluctuations in symptoms and AECOPDs, focusing on how these experiences influence health promoting behaviors, especially physical activity (PA). This study will involve an enrollment visit during which consent will be obtained, survey data will be administered (that they may take home), spirometry testing will be conducted, and a physical activity monitor (ActivPAL device) will be applied to be worn one week to allow us to understand their usual PA. A clinical ethnographic interview will then be conducted one week following enrollment, at which point the questionnaires and ActivPAL device will be collected. A second clinical ethnographic interview will be conducted one week following the first. Survey data will again collected at week 15 by mail.

Interventions

None listed

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* People who have emphysema or chronic bronchitis as their primary health problem * People who have had a respiratory infection or an exacerbation of their COPD within the last year. * People who are 55 years or older * Family member of someone who meets the above criteria.

Exclusion criteria

* Other lung diseases as their primary pulmonary problem. * Mobility problems that limit physical activity

Design outcomes

Primary

MeasureTime frameDescription
Physical activity during AECOPDweek 1Subjects will be asked to report how they managed their physical activity during the last AECOPD. Current physical activity will be measured with accelerometry and by the CHAMPS questionnaire.

Secondary

MeasureTime frameDescription
Sense of coherenceweek 1 and week 15Questionnaire that measures one's global orientation to life and the extent to which one sees life as comprehensible, manageable and meaningful.
Barriers efficacy scaleweek 1 week 15Questionnaire that measures barriers to exercise and physical activity. The subjects reports the level of confidence they have that they can overcome each barrier.
Help seeking behaviorweek 1 and week 15Questionnaire assesses help seeking with respect to healthcare services.
COPD Stigma Scaleweek 1 and week 15Questionnaire measures the stigma associated with having COPD.

Other

MeasureTime frameDescription
Social Support for Exerciseweek 1Questionnaire measures social support, positive and negative social influences for physical activity and social support for exercise.
COPD symptomsweek 1Questionnaire, the COPD Assessment Tests quantifies severity of the most recent exacerbation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026